Schrödinger, Inc.
Health
Performance
9.1
Risk
Sell
Buy
Curious about the Scores? Learn more.

Schrödinger, Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

15.11.2025
Red alert. Risk levels out of control.
10.11.2025
Rock bottom. The fall’s complete, stability nowhere to be found.
10.11.2025
Momentum tanked. Clearly underperforming.

Schrödinger, Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Schrödinger, Inc. do? Business model and key facts

Get the full picture of Schrödinger, Inc.: what it builds, where it operates, and how it makes money.

Schrödinger, Inc. Profile

Sector: Healthcare

Industry: Medical - Healthcare Information Services

Employees (FY): 891

Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

shop
Company facts
Ramy Farid
CEO
891
Employees worldwide
shop
Performance
-38.18%
Last 12 months
-82.29%
Last 5 years
shop
Growth
$207,54M
Revenue year
$-187.123.000
Net income
shop
Valuation
$1,10B
Market Cap
-7.49
Price/Earnings Ratio

Stocks related to Schrödinger, Inc.

Selected based on industry alignment and relative market positioning.

CERT
Certara, Inc.
9.68
-4.25%
9.5
Sell
Buy
Certara, Inc.
PGNY
Progyny, Inc.
24.25
-2.38%
8.0
Sell
Buy
Progyny, Inc.
OMCL
Omnicell, Inc.
49.96
-0.72%
7.5
Sell
Buy
Omnicell, Inc.
PHR
Phreesia, Inc.
15.19
-3.37%
6.9
Sell
Buy
Phreesia, Inc.
HSTM
HealthStream, Inc.
21.69
-0.55%
6.3
Sell
Buy
HealthStream, Inc.

Schrödinger, Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.